
Results in Chemistry, Год журнала: 2024, Номер unknown, С. 101769 - 101769
Опубликована: Сен. 1, 2024
Язык: Английский
Results in Chemistry, Год журнала: 2024, Номер unknown, С. 101769 - 101769
Опубликована: Сен. 1, 2024
Язык: Английский
Sustainable Chemistry and Pharmacy, Год журнала: 2024, Номер 38, С. 101497 - 101497
Опубликована: Фев. 21, 2024
A sustainable hydrogel-based drug delivery system for pH-sensitive of doxorubicin (DOX) as a model has been developed the first time to address some complications chemotherapy. The biobased nanocomposite comprising hydroxyapatite (HAP) nanoparticles loaded in biodegradable poly(acrylic acid) (PAA)/polyethylene glycol (PEG) hydrogel network was prepared via double emulsion method using bitter almond oil and span 80 surfactant. Double emulsions can expand release drugs longer period well increase their bioavailability tumor tissues. Multiple analyses were conducted assess structure nanocarriers therapeutic efficiency. XRD FTIR corroborated successful synthesis gave insight into crystalline nature molecular interactions between components. DLS revealed monodispersity nanocarriers, with an average size 418 nm. TEM SEM showed spherical porous morphology zeta potential measurements indicated surface charge −34.5 mV, thus corroborating excellent stability suitability long storage. loading entrapment efficiencies (46% 87.5%, respectively) higher than those reported previously similar nanocarriers. An effective sustained profile observed at pH 5.4. MMT assay flow cytometric that satisfactory cytotoxicity compared free DOX.
Язык: Английский
Процитировано
7Journal of Drug Delivery Science and Technology, Год журнала: 2024, Номер 102, С. 106394 - 106394
Опубликована: Ноя. 8, 2024
Язык: Английский
Процитировано
4Inorganic Chemistry Communications, Год журнала: 2025, Номер unknown, С. 114290 - 114290
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0Nanotechnology Reviews, Год журнала: 2025, Номер 14(1)
Опубликована: Янв. 1, 2025
Abstract Osteosarcoma (OS) is the most frequent primary malignant bone tumor in adolescents and young adults. Despite advances therapy, OS remains an ominous problem because of its high metastatic potential, resistance to standard great physical, psychological, financial burden on patients. Available treatment options like surgery high-dose chemotherapy are limited by chemotoxicity, multimed resistance, adverse effects quality life Extrapolated from wide array vitro vivo studies, application kinase inhibitors targeting oncogenic signaling pathways, such as insulin-like growth factor 1 receptor, PDGFR, PI3K/AKT/mTOR pathway, appears quite promising. However, patients plagued with challenges poor bioavailability, off-target effects, mechanisms, which prevent clinical application. This review explores how nanotechnology beginning meet these challenges. Liposomes, polymeric nanoparticles, metallic nanoparticles among that provide new solutions for delivery bioavailability inhibitors, reducing systemic toxicity enhancing therapeutic accuracy. Active or passive enabled nanocarriers, enable drugs specifically act tissues while minimizing healthy cells. Additionally, diagnostic functionalities combined into theranostic platforms through pave way personalized medicine approaches. Nanoparticle-based have shown efficacy preclinical setting overcome drug improve targeting, sustained release drug. These dramatic improving outcomes at much less than currently available treatments. shows need further exploration bridge exciting findings practice. Future studies should seek optimize nanoparticle design evade enhance target specificity, reduce time-dependent toxicity. Further, incorporation a strategy has possibility changing treated bringing promise better patient life.
Язык: Английский
Процитировано
0Results in Chemistry, Год журнала: 2024, Номер unknown, С. 101769 - 101769
Опубликована: Сен. 1, 2024
Язык: Английский
Процитировано
1